Role of Artificial Intelligence and Real-Time Clinical Decision Support System in Enhancing Antimicrobial Stewardship for Pneumonia Management: A Scoping Review

Main Article Content

Muhammad Jawad Hassan
Nor Elina Alias
Zulfikri Abdul Hamid
Sohail Riaz
Norny Syafinaz Ab Rahman

Abstract

Antimicrobial resistance (AMR) is a major public health challenge globally, particularly in pneumonia where inappropriate antibiotic use is common, resulting in increased morbidity and mortality. Artificial intelligence (AI) and clinical decision support systems (CDSS) have emerged as key tools to enhance antimicrobial stewardship (AMS) practices and reduce AMR. This scoping review aims to present and map the current AI and real-time CDSS applications in AMS for pneumonia patients, focusing on their types used and associated outcomes. This scoping review was conducted according to Arksey and O’Malley methodological framework and reported according to the PRISMA-ScR checklist. Databases including PubMed, CINAHL, EMBASE, and Scopus, were searched between April and August 2025. Original studies published in English between 2015 and 2025 were included. Out of 505 identified articles, 11 eligible studies were analysed. The findings showed that AI and CDSS tools, when integrated with machine learning (ML) algorithms and large databases, enhance diagnostic accuracy, optimise antibiotic use, improve pathogen identification, enhance AMR detection, promote guideline adherence, and support treatment-related decisions, thereby reducing mortality, healthcare costs, and the overuse of broad-spectrum antibiotics. However, integrating these technologies into clinical workflows remains a challenge due to limited research in low- and middle-income countries, data quality issues, and associated ethical concerns. AI and the CDSS are promising technologies to enhance AMS, especially in pneumonia, with improved patient outcomes. Future research to validate these technologies in diverse settings, while addressing barriers to their implementation and ethical concerns, is needed to enhance AMS practices and reduce AMR globally.

Article Details

How to Cite
Hassan, M. J. ., Alias, N. E. ., Abdul Hamid, Z., Riaz, S., & Ab Rahman, N. S. (2026). Role of Artificial Intelligence and Real-Time Clinical Decision Support System in Enhancing Antimicrobial Stewardship for Pneumonia Management: A Scoping Review. Journal of Pharmacy, 6(1), 35–51. https://doi.org/10.31436/jop.v6i1.463
Section
Pharmacy Practice & Education

References

ACSQHC. (2023). Antimicrobial stewardship. Australian Commission on Safety and Quality in Health Care. Retrieved 30 May 2025 from https://www.safetyandquality.gov.au/our-work/antimicrobial-stewardship

Alami, H., Rivard, L., Lehoux, P., Hoffman, S. J., Cadeddu, S. B. M., Savoldelli, M., Samri, M. A., Ag Ahmed, M. A., Fleet, R., & Fortin, J.-P. (2020). Artificial intelligence in health care: laying the foundation for responsible, sustainable, and inclusive innovation in low-and middle-income countries. Globalization and Health, 16(1), 52. https://doi.org/10.1186/s12992-020-00584-1 DOI: https://doi.org/10.1186/s12992-020-00584-1

AlGain, S., Marra, A. R., Kobayashi, T., Marra, P. S., Celeghini, P. D., Hsieh, M. K., Shatari, M. A., Althagafi, S., Alayed, M., & Ranavaya, J. I. (2025). Can we rely on artificial intelligence to guide antimicrobial therapy? A systematic literature review. Antimicrobial Stewardship & Healthcare Epidemiology, 5(1), e90. https://doi.org/10.1017/ash.2025.47 DOI: https://doi.org/10.1017/ash.2025.47

Arksey, H., & O'malley, L. (2005). Scoping studies: towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19-32. https://doi.org/10.1080/1364557032000119616 DOI: https://doi.org/10.1080/1364557032000119616

Behar, J. A., Levy, J., & Celi, L. A. (2023). Generalization in medical AI: a perspective on developing scalable models. arXiv preprint arXiv:2311.05418. https://doi.org/10.48550/arXiv.2311.05418

Bender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R.-M. V., Novotney, A., Wool, E. E., Ikuta, K. S., Vongpradith, A., Rogowski, E. L. B., & Doxey, M. (2024). Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases, 24(9), 974-1002. https://doi.org/10.1016/S1473-3099(24)00176-2

Bienvenu, A. L., Ducrocq, J.-M., Augé-Caumon, M.-J., & Baseilhac, E. (2025). Clinical decision support system to guide antimicrobial selection: a narrative review from 2019 to 2023. Journal of Hospital Infection. https://doi.org/10.1016/j.jhin.2025.05.001 DOI: https://doi.org/10.1016/j.jhin.2025.05.001

Bilal, H., Khan, M. N., Khan, S., Shafiq, M., Fang, W., Khan, R. U., Rahman, M. U., Li, X., Lv, Q. L., & Xu, B. (2025). The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance. Comput Struct Biotechnol J, 27, 423-439. https://doi.org/10.1016/j.csbj.2025.01.006 DOI: https://doi.org/10.1016/j.csbj.2025.01.006

CDC. (2024). Antibiotic Use and Stewardship in the United States, 2024 Update: Progress and Opportunities. Centers for Disease Control and Prevention. Retrieved 10 April 2025 from https://www.cdc.gov/antibiotic-use/hcp/data-research/stewardship-report.html

Chakshu, N. K., & Nithiarasu, P. (2022). An AI based digital-twin for prioritising pneumonia patient treatment. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, 236(11), 1662-1674. https://doi.org/10.1177/09544119221123431 DOI: https://doi.org/10.1177/09544119221123431

Ciarkowski, C. E., Timbrook, T. T., Kukhareva, P. V., Edholm, K. M., Hatton, N. D., Hopkins, C. L., Thomas, F., Sanford, M. N., Igumnova, E., & Benefield, R. J. (2020). A pathway for community-acquired pneumonia with rapid conversion to oral therapy improves health care value. Open Forum Infectious Diseases, 7(11), ofaa497. https://doi.org/10.1093/ofid/ofaa497 DOI: https://doi.org/10.1093/ofid/ofaa497

Cilloniz, C., Martin-Loeches, I., Garcia-Vidal, C., San Jose, A., & Torres, A. (2016). Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. International Journal of Molecular Sciences, 17(12), 2120. https://doi.org/10.3390/ijms17122120 DOI: https://doi.org/10.3390/ijms17122120

Dean, N. C., Jones, B. E., Jones, J. P., Ferraro, J. P., Post, H. B., Aronsky, D., Vines, C. G., Allen, T. L., & Haug, P. J. (2015). Impact of an electronic clinical decision support tool for emergency department patients with pneumonia. Annals of Emergency Medicine, 66(5), 511-520. https://doi.org/10.1016/j.annemergmed.2015.02.003 DOI: https://doi.org/10.1016/j.annemergmed.2015.02.003

Dean, N. C., Vines, C. G., Carr, J. R., Rubin, J. G., Webb, B. J., Jacobs, J. R., Butler, A. M., Lee, J., Jephson, A. R., & Jenson, N. (2022). A pragmatic, stepped-wedge, cluster-controlled clinical trial of real-time pneumonia clinical decision support. American Journal of Respiratory and Critical Care Medicine, 205(11), 1330-1336. https://doi.org/10.1164/rccm.202109-2092OC DOI: https://doi.org/10.1164/rccm.202109-2092OC

Duvel, J. A., Lampe, D., Kirchner, M., Elkenkamp, S., Cimiano, P., Düsing, C., Marchi, H., Schmiegel, S., Fuchs, C., & Claben, S. (2025). An AI-Based Clinical Decision Support System for Antibiotic Therapy in Sepsis (KINBIOTICS): Use Case Analysis. JMIR Human Factors, 12(1), e66699. https://doi.org/10.2196/66699 DOI: https://doi.org/10.2196/66699

Free, R. C., Lozano Rojas, D., Richardson, M., Skeemer, J., Small, L., Haldar, P., & Woltmann, G. (2023). A data-driven framework for clinical decision support applied to pneumonia management. Frontiers in Digital Health, 5, 1237146. https://doi.org/10.3389/fdgth.2023.1237146 DOI: https://doi.org/10.3389/fdgth.2023.1237146

Gadsby Naomi, J., & Musher Daniel, M. (2022). The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures. Clinical Microbiology Reviews, 35(4), e00015-00022. https://doi.org/10.1128/cmr.00015-22 DOI: https://doi.org/10.1128/cmr.00015-22

Gohil, S. K., Septimus, E., Kleinman, K., Varma, N., Avery, T. R., Heim, L., Rahm, R., Cooper, W. S., Cooper, M., McLean, L. E., Nickolay, N. G., Weinstein, R. A., Burgess, L. H., Coady, M. H., Rosen, E., Sljivo, S., Sands, K. E., Moody, J., Vigeant, J., Rashid, S., Gilbert, R. F., Smith, K. N., Carver, B., Poland, R. E., Hickok, J., Sturdevant, S. G., Calderwood, M. S., Weiland, A., Kubiak, D. W., Reddy, S., Neuhauser, M. M., Srinivasan, A., Jernigan, J. A., Hayden, M. K., Gowda, A., Eibensteiner, K., Wolf, R., Perlin, J. B., Platt, R., & Huang, S. S. (2024). Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The Inspire Randomized Clinical Trial. Jama, 331(23), 2007-2017. https://doi.org/10.1001/jama.2024.6248 DOI: https://doi.org/10.1001/jama.2024.6248

Gorman, S. K., Pro, R. S. S., Dresser, L. D., & Con, P. E. B. (2016). Should traditional antimicrobial stewardship (AMS) models incorporating clinical pharmacists with full-time AMS responsibilities be replaced by models in which pharmacists simply participate in AMS activities as part of their routine ward or team-based pharmaceutical care? Canadian Journal of Hospital Pharmacy, 69(1). https://doi.org/10.4212/cjhp.v69i1.1523 DOI: https://doi.org/10.4212/cjhp.v69i1.1523

Jian, M., Jr., Tai-Han, L., Hsing-Yi, C., Chih-Kai, C., Cherng-Lih, P., Feng-Yee, C., & and Shang, H.-S. (2024a). Artificial Intelligence-Clinical Decision Support System in Infectious Disease Control: Combatting Multidrug-Resistant Klebsiella pneumoniae with Machine Learning. Infection and Drug Resistance, 17, 2899-2912. https://doi.org/10.2147/IDR.S470821 DOI: https://doi.org/10.2147/IDR.S470821

Jian, M., Jr., Tai-Han, L., Hsing-Yi, C., Chih-Kai, C., Cherng-Lih, P., Feng-Yee, C., & and Shang, H.-S. (2024b). Pioneering Klebsiella Pneumoniae Antibiotic Resistance Prediction With Artificial Intelligence-Clinical Decision Support System–Enhanced Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry: Retrospective Study. Journal of Medical Internet Research, 26, e58039. https://doi.org/10.2196/58039 DOI: https://doi.org/10.2196/58039

Khadem, T. M., Ergen, H. J., Salata, H. J., Andrzejewski, C., McCreary, E. K., Abdel Massih, R. C., & Bariola, J. R. (2022). Impact of Clinical Decision Support System Implementation at a Community Hospital With an Existing Tele-Antimicrobial Stewardship Program. Open Forum Infectious Diseases, 9(7), ofac235. https://doi.org/10.1093/ofid/ofac235 DOI: https://doi.org/10.1093/ofid/ofac235

Laka, M., Milazzo, A., & Merlin, T. (2020). Can evidence-based decision support tools transform antibiotic management? A systematic review and meta-analyses. Journal of Antimicrobial Chemotherapy, 75(5), 1099-1111. https://doi.org/10.1093/jac/dkz543 DOI: https://doi.org/10.1093/jac/dkz543

Levac, D., Colquhoun, H., & O'brien, K. K. (2010). Scoping studies: advancing the methodology. Implementation Science, 5(1), 69. https://doi.org/10.1186/1748-5908-5-69 DOI: https://doi.org/10.1186/1748-5908-5-69

Lim, W. S. (2022). Pneumonia-Overview. In Encyclopedia of Respiratory Medicine (Second Edition) (2 ed.). Academic Press. https://doi.org/10.1016/B978-0-12-801238-3.11636-8 DOI: https://doi.org/10.1016/B978-0-12-801238-3.11636-8

Lin, T.-H., Chung, H.-Y., Jian, M., Jr., Chang, C.-K., Lin, H.-H., Yu, C.-M., Perng, C.-L., Chang, F.-Y., Chen, C.-W., Chiu, C.-H., & Shang, H.-S. (2024). Artificial intelligence-clinical decision support system for enhanced infectious disease management: Accelerating ceftazidime-avibactam resistance detection in Klebsiella pneumoniae. Journal of Infection and Public Health, 17(10), 102541. https://doi.org/https://doi.org/10.1016/j.jiph.2024.102541 DOI: https://doi.org/10.1016/j.jiph.2024.102541

Marinescu, S. A., Oncioiu, I., & Ghibanu, A.-I. (2025). The Digital Transformation of Healthcare Through Intelligent Technologies: A Path Dependence-Augmented–Unified Theory of Acceptance and Use of Technology Model for Clinical Decision Support Systems. Healthcare, 13(11), 1222. https://doi.org/10.3390/healthcare13111222 DOI: https://doi.org/10.3390/healthcare13111222

Morley, J., Machado, C. C. V., Burr, C., Cowls, J., Joshi, I., Taddeo, M., & Floridi, L. (2020). The ethics of AI in health care: A mapping review. Social Science & Medicine, 260, 113172. https://doi.org/https://doi.org/10.1016/j.socscimed.2020.113172 DOI: https://doi.org/10.1016/j.socscimed.2020.113172

Müller, L., Srinivasan, A., Abeles, S. R., Rajagopal, A., Torriani, F. J., & Aronoff-Spencer, E. (2021). A risk-based clinical decision support system for patient-specific antimicrobial therapy (iBiogram): design and retrospective analysis. Journal of Medical Internet Research, 23(12), e23571. https://doi.org/10.2196/23571 DOI: https://doi.org/10.2196/23571

Munn, Z., Peters, M. D. J., Stern, C., Tufanaru, C., McArthur, A., & Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology, 18(1), 143. https://doi.org/10.1186/s12874-018-0611-x DOI: https://doi.org/10.1186/s12874-018-0611-x

Murray, C. J., Ikuta, K. S., Sharara, F., Swetschinski, L., Aguilar, G. R., Gray, A., Han, C., Bisignano, C., Rao, P., & Wool, E. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629-655. https://doi.org/10.1016/S0140-6736(21)02724-0

Nguyen, H.-A., Peleg, A. Y., Song, J., Antony, B., Webb, G. I., Wisniewski, J. A., Blakeway, L. V., Badoordeen, G. Z., Theegala, R., & Zisis, H. (2024). Predicting Pseudomonas aeruginosa drug resistance using artificial intelligence and clinical MALDI-TOF mass spectra. MSystems, 9(9), e00789-00724. https://doi.org/10.1128/msystems.00789-24 DOI: https://doi.org/10.1128/msystems.00789-24

Niederman, M. S., & Torres, A. (2022). Respiratory infections. European Respiratory Review, 31(166), 220150. https://doi.org/10.1183/16000617.0150-2022 DOI: https://doi.org/10.1183/16000617.0150-2022

Otaigbe, I. I. (2023). Achieving universal health coverage in low-and middle-income countries through digital antimicrobial stewardship. Frontiers in Digital Health, 5, 1298861. https://doi.org/10.3389/fdgth.2023.1298861 DOI: https://doi.org/10.3389/fdgth.2023.1298861

Panagoulias, D. P., Virvou, M., & Tsihrintzis, G. A. (2023, 4-6 December 2023). An Empirical Study Concerning the Impact of Perceived Usefulness and Ease of Use on the Adoption of AI-Empowered Medical Applications. IEEE 23rd International Conference on Bioinformatics and Bioengineering (BIBE), 338-345. https://doi.org/10.1109/BIBE60311.2023.00062 DOI: https://doi.org/10.1109/BIBE60311.2023.00062

Pennisi, F., Pinto, A., Ricciardi, G. E., Signorelli, C., & Gianfredi, V. (2025). The Role of Artificial Intelligence and Machine Learning Models in Antimicrobial Stewardship in Public Health: A Narrative Review. Antibiotics (Basel), 14(2). https://doi.org/10.3390/antibiotics14020134 DOI: https://doi.org/10.3390/antibiotics14020134

Pinto-de-Sa, R., Sousa-Pinto, B., & Costa-de-Oliveira, S. (2024). Brave New World of Artificial Intelligence: Its Use in Antimicrobial Stewardship-A Systematic Review. Antibiotics (Basel), 13(4). https://doi.org/10.3390/antibiotics13040307 DOI: https://doi.org/10.3390/antibiotics13040307

Pollock, D., Peters, M. D. J., Khalil, H., McInerney, P., Alexander, L., Tricco, A. C., Evans, C., de Moraes, É. B., Godfrey, C. M., Pieper, D., Saran, A., Stern, C., & Munn, Z. (2023). Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evidence Synthesis, 21(3), 520-532. https://doi.org/10.11124/jbies-22-00123 DOI: https://doi.org/10.11124/JBIES-22-00123

Rittmann, B., & Stevens, M. P. (2019). Clinical Decision Support Systems and Their Role in Antibiotic Stewardship: a Systematic Review. Current Infectious Disease Reports, 21(8), 29. https://doi.org/10.1007/s11908-019-0683-8 DOI: https://doi.org/10.1007/s11908-019-0683-8

Rockenschaub, P., Hilbert, A., Kossen, T., Elbers, P., von Dincklage, F., Madai, V. I., & Frey, D. (2024). The Impact of Multi-Institution Datasets on the Generalizability of Machine Learning Prediction Models in the ICU. Critical Care Medicine, 52(11), 1710-1721. https://doi.org/10.1097/ccm.0000000000006359 DOI: https://doi.org/10.1097/CCM.0000000000006359

Sekandarzad, A., Flügler, A., Rheinboldt, A., Rother, D., Först, G., Rieg, S., Supady, A., Lother, A., Staudacher, D. L., & Wengenmayer, T. (2025). Reduced antimicrobial consumption through enhanced pneumonia management in critically ill patients: outcomes of an antibiotic stewardship program in the intensive care unit. Frontiers in Medicine, 12, 1549355. https://doi.org/10.3389/fmed.2025.1549355 DOI: https://doi.org/10.3389/fmed.2025.1549355

Szymczak, J. E., Hayes, A. A., Labellarte, P., Zighelboim, J., Toor, A., Becker, A. B., Gerber, J. S., Kuppermann, N., & Florin, T. A. (2024). Parent and clinician views on not using antibiotics for mild community-acquired pneumonia. Pediatrics, 153(2), e2023063782. https://doi.org/doi.org/10.1542/peds.2023-063782 DOI: https://doi.org/10.1542/peds.2023-063782

Torres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., Paiva, J. A., Read, R. C., Rigau, D., Timsit, J. F., Welte, T., & Wunderink, R. (2017). The International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. European Respiratory Journal, 50(3), 1700582. https://doi.org/10.1183/13993003.00582-2017 DOI: https://doi.org/10.1183/13993003.00582-2017

Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D., Horsley, T., & Weeks, L. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.7326/m18-0850 DOI: https://doi.org/10.7326/M18-0850

UniSA. (2025). Data extraction for scoping review. University of South Australia. Retrieved 23 May 2025 from https://guides.library.unisa.edu.au/ScopingReviews/DataExtraction

WHO. (2019). Antimicrobial Stewardship Programmes in Health Care Facilities in Low and Middle-Income Countries: A WHO Practical Toolkit. World Health Organisation. Retrieved 30 May 2025 from https://www.who.int/publications/i/item/9789241515481

WHO. (2023). Antimicrobial resistance. World Health Organisation. Retrieved 05 April 2025 from https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

Zhang, X., Yu, P., Yan, J., & Ton AM Spil, I. (2015). Using diffusion of innovation theory to understand the factors impacting patient acceptance and use of consumer e-health innovations: a case study in a primary care clinic. BMC Health Services Research, 15(1), 71. DOI: https://doi.org/10.1186/s12913-015-0726-2

Most read articles by the same author(s)

1 2 > >>